Name | BERLIN-FARMA, ZAO |
|---|
INN | 7714033558 |
|---|
KPP | 402901001 |
|---|
OGRN | 1027739581968 |
|---|
OKPO | 40305100 |
|---|
Address | 248926, Kaluzhskaya Oblast', g Kaluga, pr-d 2-y Avtomobil'nyy, d. D. 5 |
|---|
Phone | +7 (484) 290-95-00 |
|---|
Fax | 90-95-01 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 21.20.1 | Core activity | Production of drugs |
Registration date | 20.11.2002 |
|---|
Registering department | Gosudarstvennoe uchrezhdenie Moskovskaya registratsionnaya palata |
|---|
|
BERLIN-FARMA, ZAO (Moscow; INN 7714033558) was registered on 20 Nov 2002. The company's authorized capital as of July 1, 2012 was 900100000 rub. Type of ownership of BERLIN-FARMA, ZAO - Closed joint-stock companies. Form of ownership of BERLIN-FARMA, ZAO - Property of foreign legal entities. Principal activities of BERLIN-FARMA, ZAO: production of drugs (21.20.1). |
Economic indicators2023
Net profit (RAS) of BERLIN-FARMA, ZAO grew over 2023 by 43.95% to 395.94 million RUB from 275.05 million RUB over 2022, the company informed. Revenue increased in the accounting period by 4.59% to 4.34 billion RUB from 4.15 billion RUB over 2022; cost of goods sold remained at the same level amounting to 3.63 billion RUB compared to 3.63 billion RUB; sales profit went up by 46.84% to 616.57 million RUB from 419.89 million RUB. 2022
Net profit (RAS) of BERLIN-FARMA, ZAO dropped in 2022 by 11.73% to 275.05 million RUB from 311.60 million RUB over the same period in 2021, the company informed. Revenue decreased in the accounting period by 27.34% to 4.15 billion RUB from 5.71 billion RUB in 2021; cost of goods sold decreased by 30.32% to 3.63 billion RUB from 5.20 billion RUB; sales profit went up by 5.44% to 419.89 million RUB from 398.24 million RUB. 2021
Net profit (RAS) of BERLIN-FARMA, ZAO grew over 2021 by 4.64% to 311.60 million RUB from 297.79 million RUB over 2020, the company informed. Revenue increased in the accounting period by 15.16% to 5.71 billion RUB from 4.95 billion RUB over 2020; cost of goods sold grew by 17.01% to 5.20 billion RUB from 4.45 billion RUB; sales profit fell by 1.25% to 398.24 million RUB from 403.28 million RUB. 2020
Net profit (RAS) of BERLIN-FARMA, ZAO dropped in 2020 by 34.69% to 297.79 million RUB from 455.95 million RUB over the same period in 2019, the company informed. Revenue decreased in the accounting period by 15.40% to 4.95 billion RUB from 5.86 billion RUB in 2019; cost of goods sold decreased by 14.16% to 4.54 billion RUB from 5.29 billion RUB; sales profit fell by 27.90% to 403.28 million RUB from 559.31 million RUB. 2018
Net profit (RAS) of BERLIN-FARMA, ZAO dropped in 2018 2.47 times to 236.95 million RUB from 586.05 million RUB over the same period in 2017, the company informed. Revenue increased in the accounting period by 19.28% to 4.34 billion RUB from 3.64 billion RUB over 2017; cost of goods sold grew by 43.19% to 4.17 billion RUB from 2.91 billion RUB; sales profit fell 4.29 times to 168.90 million RUB from 725.06 million RUB. 2017
Net profit (RAS) of BERLIN-FARMA, ZAO dropped in 2017 by 38.79% to 586.05 million RUB from 957.37 million RUB over the same period in 2016, the company informed. Revenue increased in the accounting period by 5.81% to 3.64 billion RUB from 3.44 billion RUB over 2016; cost of goods sold grew by 20.14% to 2.91 billion RUB from 2.42 billion RUB; sales profit fell by 28.47% to 725.06 million RUB from 1.01 billion RUB. 2016
Net profit (RAS) of BERLIN-FARMA, ZAO grew over 2016 4.89 times to 956.56 million RUB from 195.64 million RUB over 2015, the company informed. Revenue increased in the accounting period by 46.72% to 3.44 billion RUB from 2.35 billion RUB over 2015; cost of goods sold grew by 37.08% to 2.42 billion RUB from 1.77 billion RUB; sales profit went up 1.76 times to 1.01 billion RUB from 574.46 million RUB. 2014
Net loss (RAS) of BERLIN-FARMA, ZAO increased 2.35 times to 444.89 million RUB from 189.08 million RUB over 2013, the company informed. Sales profit made up 162.48 million RUB compared to sales loss of 239.67 million RUB. 2013
Net loss (RA) of BERLIN-FARMA, ZAO made up 199.54 million RUB over 2013 compared to net profit of 258.62 million RUB over 2012, the company informed. Revenue decreased in the accounting period 442.28 times to 24.31 million RUB from 10.75 billion RUB in 2012; cost of goods sold decreased 1,920.67 times to 5.53 million RUB from 10.62 billion RUB; sales profit made up 18.78 million RUB compared to sales loss of 164.67 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|